Quit Smoking Text Messages for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help people quit smoking using text messages and possibly a smartband. The goal is to assess the effectiveness of a text messaging program called SmokefreeTXT, with or without the added support of a smartband (a wearable smoking detector), for individuals trying to quit smoking. It suits those who have smoked daily for at least six months and are eager to quit. Participants should not engage in any other quit-smoking programs while participating in this one. As an unphased trial, this study provides a unique opportunity to explore innovative methods for quitting smoking.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that SmokefreeTXT is generally easy to use. This program sends text messages to motivate and provide tips for quitting smoking. Studies have not identified any major negative side effects from using this service.
For SmokefreeTXT combined with a smartband, research also indicates safety. The smartband helps users track and become aware of their smoking habits. While the band aims to help people notice when they smoke, no serious negative effects have been reported.
Both options focus on changing behavior, making them low-risk. Overall, these tools are designed to help people quit smoking without causing harm.12345Why are researchers excited about this trial?
SmokefreeTXT sets itself apart by offering a personalized, text-based approach to quitting smoking, which is more accessible and continuous compared to traditional methods like nicotine replacement therapies or prescription medications. The addition of a smartband in the experimental arm introduces a novel way to monitor and support behavior change through real-time feedback and data tracking. This digital and wearable tech combination provides a more engaging and interactive experience, which researchers believe could enhance motivation and adherence, ultimately boosting success rates in smoking cessation.
What evidence suggests that this trial's treatments could be effective for smoking cessation?
Research shows that SmokefreeTXT, a text messaging program, helps people quit smoking. Studies have found that text messages can boost the chances of quitting by 63%. One study discovered that people who used a 12-week text message program were more likely to quit smoking at 3 and 6 months than those who didn't use it.
In this trial, participants will be randomized into different treatment arms. One arm will receive SmokefreeTXT alone, while another will receive SmokefreeTXT combined with a smartband. The smartband detects smoking and sends real-time alerts, increasing awareness of smoking habits, which can lead to better quitting results. Using both text messages and smartband feedback together may provide stronger support for quitting smoking.12367Who Is on the Research Team?
Kathleen A Garrison, PhD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for daily smokers who have been smoking for at least six months and are interested in quitting. It's not open to individuals already enrolled in another quit smoking program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the SmokefreeTXT program with or without a smartband for smoking cessation
Follow-up
Participants are monitored for smoking cessation outcomes and relapse
What Are the Treatments Tested in This Trial?
Interventions
- Smartband
- SmokefreeTXT
Trial Overview
The study is testing the effectiveness of a quit smoking text messaging service called SmokefreeTXT, with some participants also using a smartband. Participants will be randomly placed into groups to receive either just the texts or texts plus the smartband.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT + smartband.
Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT.
SmokefreeTXT is already approved in United States for the following indications:
- Smoking cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
American Lung Association
Collaborator
Published Research Related to This Trial
Citations
User Experiences With an SMS Text Messaging Program ...
SmokefreeTXT comprises 6 to 8 weeks of SMS text messages that provide cessation motivation, tips on preparing to quit, advice on managing ...
Effectiveness of an optimized text message and Internet ...
To evaluate the effectiveness of a combined internet and text message intervention for smoking cessation compared with an internet intervention alone.
Efficacy of digital interventions for smoking cessation by ...
SMS interventions demonstrated the highest efficacy (RR 1.63, 95% CI 1.38–1.92), indicating a 63% increased smoking cessation success compared ...
Effects of a text messaging smoking cessation intervention ...
Access to a 12-week text messaging intervention produced higher self-reported smoking abstinence at 3 and 6 months post-randomisation amongst ...
Assessment of a Text Message–Based Smoking Cessation ...
In this study, the behavior change theory–based smoking cessation intervention using personalized text messages was more effective than an intervention using ...
Outcomes of a Comprehensive Mobile Smoking Cessation ...
SMS text messaging with tobacco treatment specialists was negatively associated with quit outcomes at 6 months; however, the authors suggest ...
Outcomes of a Comprehensive Mobile Smoking Cessation ...
At 3 months, Average Treatment Effects weighted abstinence rates were 4.2% for those who did not use the web-based community, 15.1% for those ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.